title: Comment on "The abrupt cessation of therapeutically administered sodium oxybate (GHB) may cause withdrawal symptoms".
authors.forename: Deborah L
authors.initials: DL
authors.lastname: Zvosec
authors.forename: Stephen W
authors.initials: SW
authors.lastname: Smith
mesh_terms: D002385:Cataplexy / Q000150:complications / Q000503:physiopathology; D006801:Humans; D012189:Retrospective Studies; D012978:Sodium Oxybate / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000209:etiology* / Q000503:physiopathology
chemical_list: D012978:Sodium Oxybate